Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients

被引:10
作者
Takekita, Yoshiteru [1 ,2 ]
Fabbri, Chiara [1 ]
Kato, Masaki [2 ]
Nonen, Shinpei [3 ]
Sakai, Shiho [2 ]
Sunada, Naotaka [2 ]
Koshikawa, Yosuke [2 ]
Wakeno, Masataka [2 ]
Okugawa, Gaku [2 ]
Kinoshita, Toshihiko [2 ]
Serretti, Alessandro [1 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, IT-40123 Bologna, Italy
[2] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan
[3] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan
基金
日本学术振兴会;
关键词
5-HT; Antipsychotics; Polymorphism; Schizophrenia; HTR7; Second-generation antipsychotics; Pharmacogenetics; Efficacy; HIPPOCAMPAL GLUCOCORTICOID RECEPTOR; 5-HT7; RECEPTOR; ANTAGONIST SB-269970; PREFRONTAL CORTEX; CIRCADIAN CLOCK; ANIMAL-MODELS; 1ST EPISODE; GENE; EXPRESSION; SLEEP;
D O I
10.1159/000441629
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individual differences in serotonin 7 receptor (5-HT7R) may result in variable response to antipsychotics with 5-HT7R antagonism. This study investigated the relationship between single nucleotide polymorphisms (SNPs) in the 5-HT7R gene (HTR7) and the efficacy of second-generation antipsychotic drugs with a high affinity for this receptor in Japanese schizophrenia. Methods: Perospirone or aripiprazole was administered to 100 patients with schizophrenia in a randomized controlled study. All patients were genotyped for three candidate SNPs (rs12412496, rs7916403, and rs1935349). Patient improvement on the Positive and Negative Syndrome Scale (PANSS) total score at 12 weeks was assessed as the primary outcome. PANSS 5-factor scores were investigated as the secondary outcome. Results: Improvement on the PANSS total score and genetic polymorphisms showed no correlation. The rs12412496-rs7916403-rs1935349 A-T-A haplotype was correlated with worse improvement in the cognition score (haplotype frequency: 0.285, p = 0.046, permuted p = 0.043). Conclusion: Our results show that HTR7 variants are not related to the overall improvement in schizophrenia symptoms. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:118 / 125
页数:8
相关论文
共 58 条
  • [41] Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
    Nikiforuk, Agnieszka
    Kos, Tomasz
    Fijal, Katarzyna
    Holuj, Malgorzata
    Rafa, Dominik
    Popik, Piotr
    [J]. PLOS ONE, 2013, 8 (06):
  • [42] Amisulpride promotes cognitive flexibility in rats: The role of 5-HT7 receptors
    Nikiforuk, Agnieszka
    Popik, Piotr
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2013, 248 : 136 - 140
  • [43] Mice lacking 5-HT7 receptors show specific impairments in contextual learning
    Roberts, AJ
    Krucker, T
    Levy, CL
    Slanina, KA
    Sutcliffe, JG
    Hedlund, PB
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (07) : 1913 - 1922
  • [44] Robinson DG, 1999, AM J PSYCHIAT, V156, P544
  • [45] ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403
  • [46] MOLECULAR-CLONING, CHARACTERIZATION, AND LOCALIZATION OF A HIGH-AFFINITY SEROTONIN RECEPTOR (5-HT(7)) ACTIVATING CAMP FORMATION
    RUAT, M
    TRAIFFORT, E
    LEURS, R
    TARDIVELLACOMBE, J
    DIAZ, J
    ARRANG, JM
    SCHWARTZ, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8547 - 8551
  • [47] HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia
    Takekita, Yoshiteru
    Fabbri, Chiara
    Kato, Masaki
    Nonen, Shinpei
    Sakai, Shiho
    Sunada, Naotaka
    Koshikawa, Yosuke
    Wakeno, Masataka
    Okugawa, Gaku
    Kinoshita, Toshihiko
    Serretti, Alessandro
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 220 - 227
  • [48] A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
    Takekita, Yoshiteru
    Kato, Masaki
    Wakeno, Masataka
    Sakai, Shiho
    Suwa, Azusa
    Nishida, Keiichiro
    Okugawa, Gaku
    Kinoshita, Toshihiko
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 110 - 114
  • [49] 5-HT7 Receptors
    Thomas, David R.
    Hagan, Jim J.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (01) : 81 - 90
  • [50] SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats
    Thomas, DR
    Melotto, S
    Massagrande, M
    Gribble, AD
    Jeffrey, P
    Stevens, AJ
    Deeks, NJ
    Eddershaw, PJ
    Fenwick, SH
    Riley, G
    Stean, T
    Scott, CM
    Hill, MJ
    Middlemiss, DN
    Hagan, JJ
    Price, GW
    Forbes, IT
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (04) : 705 - 714